Small ruminant lentiviruses: Immunopathogenesis of visna-maedi and caprine arthritis and encephalitis virus

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 35, Issue 3, 2012, Pages 259-269

  Blacklaws, Barbara A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Caprine arthritis encephalitis virus; Dendritic cell; Goat; Immunopathogenesis; Lentivirus; Macrophage; Sheep; Small ruminant lentivirus; Tropism; Visna maedi virus

Indexed keywords

GAG PROTEIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M; INTERFERON; NEUTRALIZING ANTIBODY; VIRUS ANTIBODY; VIRUS ENVELOPE PROTEIN; VIRUS RNA; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ARTICLE; CAPRINE ARTHRITIS ENCEPHALITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; DENDRITIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MAEDI VISNA; NONHUMAN; VACCINATION; VIRAL TROPISM; VIRION; VIRUS EXPRESSION; VIRUS GENOME; VIRUS INHIBITION; VIRUS MUTATION; VIRUS REPLICATION; VIRUS TRANSCRIPTION; VIRUS TRANSMISSION;

ANIMALS; ANTIGENS, VIRAL; ARTHRITIS-ENCEPHALITIS VIRUS, CAPRINE; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; IMMUNITY, CELLULAR; LENTIVIRUS INFECTIONS; MACROPHAGE ACTIVATION; MACROPHAGES; PNEUMONIA, PROGRESSIVE INTERSTITIAL, OF SHEEP; RUMINANTS; SHEEP; VACCINATION; VIRUS REPLICATION; VISNA-MAEDI VIRUS;

CAPRA; CAPRA HIRCUS; CAPRINE ARTHRITIS-ENCEPHALITIS VIRUS; LENTIVIRUS; OVIS ARIES; SMALL RUMINANT LENTIVIRUS; VISNA/MAEDI VIRUS;

EID: 84859707974     PISSN: 01479571     EISSN: 18781667     Source Type: Journal    
DOI: 10.1016/j.cimid.2011.12.003     Document Type: Article

References (173)

1. Thormar H. Maedi-visna virus and its relationship to human immunodeficiency virus. AIDS Rev 2005, 7:233-245.
2. Pekelder J.J., Veenink G.J., Akkermans J.P., van Eldik P., Elving L., Houwers D.J. Ovine lentivirus induced indurative lymphocytic mastitis and its effect on the growth of lambs. Vet Rec 1994, 134:348-350.
3. Peterhans E., Greenland T., Badiola J., Harkiss G., Bertoni G., Amorena B., et al. Routes of transmission and consequences of small ruminant lentiviruses (SRLVs) infection and eradication schemes. Vet Res 2004, 35:257-274.
4. Leroux C., Cruz J.C., Mornex J.F. SRLVs: a genetic continuum of lentiviral species in sheep and goats with cumulative evidence of cross species transmission. Curr HIV Res 2010, 8:94-100.
5. Bertoni G., Blacklaws B.A. Small ruminant lentiviruses and cross species transmission. Lentivirus and macrophages: molecular and cellular interactions 2010, 277-306. Caister Academic Press. M. Desport (Ed.).
6. Sharp P.M., Hahn B.H. The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci 2010, 365:2487-2494.
7. Miller C., Bielefeldt-Ohmann H., Macmillan M., Huitron-Resendiz S., Henriksen S., Elder J., et al. Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. Vet Immunol Immunopathol 2011, 143:282-291.
8. Goff S.P. Retroviridae: the retroviruses and their replication. Fields virology 2007, 1999-2069. Lippincott, Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
9. Freed E.O., Martin M.A. HIVs and their replication. Fields virology 2007, 2107-2185. Lippincott, Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
10. Vigne R., Filippi P., Querat G., Sauze N., Vitu C., Russo P., et al. Precursor polypeptides to structural proteins of visna virus. J Virol 1982, 42:1046-1056.
11. Desrosiers R.C., Nonhuman lentiviruses Fields virology 2007, 2215-2243. Lippincott, Williams & Wilkins, Philadelphia. 5th ed. D.M. Knipe, P.M. Howley (Eds.).
12. Zhou W., Parent L.J., Wills J.W., Resh M.D. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 1994, 68:2556-2569.
13. Schultz A.M., Henderson L.E., Oroszlan S. Fatty acylation of proteins. Annu Rev Cell Biol 1988, 4:611-647.
14. Turelli P., Guiguen F., Mornex J.F., Vigne R., Querat G. dUTPase-minus caprine arthritis-encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. J Virol 1997, 71:4522-4530.
15. Priet S., Gros N., Navarro J.M., Boretto J., Canard B., Querat G., et al. HIV-1-associated uracil DNA glycosylase activity controls dUTP misincorporation in viral DNA and is essential to the HIV-1 life cycle. Mol Cell 2005, 17:479-490.
16. Toohey K.L., Haase A.T. The rev gene of visna virus is required for productive infection. Virology 1994, 200:276-280.
17. Tiley L.S., Brown P.H., Le S.Y., Maizel J.V., Clements J.E., Cullen B.R. Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci USA 1990, 87:7497-7501.
18. Mazarin V., Gourdou I., Querat G., Sauze N., Audoly G., Vitu C., et al. Subcellular localization of rev-gene product in visna virus-infected cells. Virology 1990, 178:305-310.
19. Villet S., Bouzar B.A., Morin T., Verdier G., Legras C., Chebloune Y. Maedi-visna virus and caprine arthritis encephalitis virus genomes encode a Vpr-like but no Tat protein. J Virol 2003, 77:9632-9638.
20. Harmache A., Russo P., Guiguen F., Vitu C., Vignoni M., Bouyac M., et al. Requirement of caprine arthritis encephalitis virus vif gene for in vivo replication. Virology 1996, 224:246-255.
21. Harmache A., Russo P., Vitu C., Guiguen F., Mornex J.F., Pepin M., et al. Replication in goats in vivo of caprine arthritis-encephalitis virus deleted in vif or tat genes: possible use of these deletion mutants as live vaccines. AIDS Res Hum Retroviruses 1996, 12:409-411.
22. Kristbjornsdottir H.B., Andresdottir V., Svansson V., Torsteinsdottir S., Matthiasdottir S., Andresson O.S. The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro. Virology 2004, 318:350-359.
23. Crane S.E., Clements J.E., Narayan O. Separate epitopes in the envelope of visna virus are responsible for fusion and neutralization: biological implications for anti-fusion antibodies in limiting virus replication. J Virol 1988, 62:2680-2685.
24. Malashkevich V.N., Singh M., Kim P.S. The trimer-of-hairpins motif in membrane fusion: visna virus. Proc Natl Acad Sci USA 2001, 98:8502-8506.
25. Narayan O., Clements J.E., Strandberg J.D., Cork L.C., Griffin D.E. Biological characterization of the virus causing leukoencephalitis and arthritis in goats. J Gen Virol 1980, 50:69-79.
26. Lee W.C., McConnell I., Blacklaws B.A. Electron microscope studies of the replication of a British isolate of maedi visna virus in macrophages and skin cell lines. Vet Microbiol 1996, 49:93-104.
27. Anderson L.W., Klevjer-Anderson P., Liggitt H.D. Susceptibility of blood-derived monocytes and macrophages to caprine arthritis-encephalitis virus. Infect Immun 1983, 41:837-840.
28. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D.E., Clements J.E. Activation of caprine arthritis encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 1983, 41:67-73.
29. Narayan O., Wolinsky J.S., Clements J.E., Strandberg J.D., Griffin D.E., Cork L.C. Slow virus-replication: the role of macrophages in the persistence and expression of visna viruses of sheep and goats. J Gen Virol 1982, 59:345-356.
30. Gendelman H.E., Narayan O., Kennedy-Stoskopf S., Kennedy P.G., Ghotbi Z., Clements J.E., et al. Tropism of sheep lentiviruses for monocytes: susceptibility to infection and virus gene expression increase during maturation of monocytes to macrophages. J Virol 1986, 58:67-74.
31. Ryan S., Tiley L., McConnell I., Blacklaws B. Infection of dendritic cells by the Maedi-Visna lentivirus. J Virol 2000, 74:10096-10103.
32. Zink M.C., Yager J.A., Myers J.D. Pathogenesis of caprine arthritis encephalitis virus. Cellular localization of viral transcripts in tissues of infected goats. Am J Pathol 1990, 136:843-854.
33. Lerondelle C., Godet M., Mornex J.F. Infection of primary cultures of mammary epithelial cells by small ruminant lentiviruses. Vet Res 1999, 30:467-474.
34. Stowring L., Haase A.T., Petursson G., Georgsson G., Palsson P., Lutley R., et al. Detection of visna virus antigens and RNA in glial cells in foci of demyelination. Virology 1985, 141:311-318.
35. Georgsson G., Houwers D.J., Palsson P.A., Petursson G. Expression of viral antigens in the central nervous system of visna-infected sheep: an immunohistochemical study on experimental visna induced by virus strains of increased neurovirulence. Acta Neuropathol 1989, 77:299-306.
36. Blacklaws B.A., Berriatua E., Torsteinsdottir S., Watt N.J., de Andres D., Klein D., et al. Transmission of small ruminant lentiviruses. Vet Microbiol 2004, 101:199-208.
37. McNeilly T.N., Baker A., Brown J.K., Collie D., Maclachlan G., Rhind S.M., et al. Role of alveolar macrophages in respiratory transmission of visna/maedi virus. J Virol 2008, 82:1526-1536.
38. McNeilly T.N., Tennant P., Lujan L., Perez M., Harkiss G.D. Differential infection efficiencies of peripheral lung and tracheal tissues in sheep infected with Visna/maedi virus via the respiratory tract. J Gen Virol 2007, 88:670-679.
39. Niesalla H., McNeilly T.N., Ross M., Rhind S.M., Harkiss G.D. Experimental infection of sheep with visna/maedi virus via the conjunctival space. J Gen Virol 2008, 89:1329-1337.
40. Gendelman H.E., Narayan O., Molineaux S., Clements J.E., Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci USA 1985, 82:7086-7090.
41. Grossi P., Giudice C., Bertoletti I., Cioccarelli G., Brocchi E., Cammarata G., et al. Immunohistochemical detection of the p27 capsid protein of caprine arthritis-encephalitis virus (CAEV) in bone-marrow cells of seropositive goats. J Comp Pathol 2005, 133:197-200.
42. Ravazzolo A.P., Nenci C., Vogt H.R., Waldvogel A., Obexer-Ruff G., Peterhans E., et al. Viral load, organ distribution, histopathological lesions, and cytokine mRNA expression in goats infected with a molecular clone of the caprine arthritis encephalitis virus. Virology 2006, 350:116-127.
43. Hotzel I., Cheevers W. Differential receptor usage of small ruminant lentiviruses in ovine and caprine cells: host range but not cytopathic phenotype is determined by receptor usage. Virology 2002, 301:21-31.
44. Hotzel I., Cheevers W.P. Host range of small-ruminant lentivirus cytopathic variants determined with a selectable caprine arthritis-encephalitis virus pseudotype system. J Virol 2001, 75:7384-7391.
45. Lyall J.W., Solanky N., Tiley L.S. Restricted species tropism of maedi-visna virus strain EV-1 is not due to limited receptor distribution. J Gen Virol 2000, 81:2919-2927.
46. Hotzel I., Cheevers W.P. A maedi-visna virus strain K1514 receptor gene is located in sheep chromosome 3p and the syntenic region of human chromosome 2. J Gen Virol 2002, 83:1759-1764.
47. Jolly P.E., Narayan O. Evidence for interference, coinfections, and intertypic virus enhancement of infection by ovine-caprine lentiviruses. J Virol 1989, 63:4682-4688.
48. Mselli-Lakhal L., Favier C., Leung K., Guiguen F., Grezel D., Miossec P., et al. Lack of functional receptors is the only barrier that prevents caprine arthritis-encephalitis virus from infecting human cells. J Virol 2000, 74:8343-8348.
49. Goodenow M.M., Collman R.G. HIV-1 coreceptor preference is distinct from target cell tropism: a dual-parameter nomenclature to define viral phenotypes. J Leukoc Biol 2006, 80:965-972.
50. Willett B.J., Hosie M.J. Chemokine receptors and co-stimulatory molecules: unravelling feline immunodeficiency virus infection. Vet Immunol Immunopathol 2008, 123:56-64.
51. Zhang B., Jin S., Jin J., Li F., Montelaro R.C. A tumor necrosis factor receptor family protein serves as a cellular receptor for the macrophage-tropic equine lentivirus. Proc Natl Acad Sci USA 2005, 102:9918-9923.
52. Crespo H., Reina R., Glaria I., Ramirez H., de Andres X., Jauregui P., et al. Identification of the ovine mannose receptor and its possible role in Visna/Maedi virus infection. Vet Res 2011, 42:28.
53. Tsegaye T.S., Pohlmann S. The multiple facets of HIV attachment to dendritic cell lectins. Cell Microbiol 2010, 12:1553-1561.
54. Haase A.T., Stowring L., Narayan P., Griffin D., Price D. Slow persistent infection caused by visna virus: role of host restriction. Science 1977, 195:175-177.
55. Narayan O., Kennedy-Stoskopf S., Sheffer D., Griffin D.E., Clements J.E. Activation of caprine arthritis-encephalitis virus expression during maturation of monocytes to macrophages. Infect Immun 1983, 41:67-73.
56. Geballe A.P., Ventura P., Stowring L., Haase A.T. Quantitative analysis of visna virus replication in vivo. Virology 1985, 141:148-154.
57. Peluso R., Haase A., Stowring L., Edwards M., Ventura P. A Trojan Horse mechanism for the spread of visna virus in monocytes. Virology 1985, 147:231-236.
58. Haase A.T. Pathogenesis of lentivirus infections. Nature 1986, 322:130-136.
59. Petursson G., Nathanson N., Georgsson G., Panitch H., Palsson P.A. Pathogenesis of visna. I. Sequential virologic, serologic, and pathologic studies. Lab Invest 1976, 35:402-412.
60. Pisoni G., Moroni P., Turin L., Bertoni G. Compartmentalization of small ruminant lentivirus between blood and colostrum in infected goats. Virology 2007, 369:119-130.
61. Mercier G., Galien R., Emanoil-Ravier R. Differential effects of ras and jun family members on complex retrovirus promoter activities. Res Virol 1994, 145:361-367.
62. Villet S., Faure C., Bouzar B.A., Morin T., Verdier G., Chebloune Y., et al. Lack of trans-activation function for Maedi Visna virus and Caprine arthritis encephalitis virus Tat proteins. Virology 2003, 307:317-327.
63. Barros S.C., Andresdottir V., Fevereiro M. Cellular specificity and replication rate of Maedi Visna virus in vitro can be controlled by LTR sequences. Arch Virol 2005, 150:201-213.
64. Gdovin S.L., Clements J.E. Molecular mechanisms of visna virus Tat: identification of the targets for transcriptional activation and evidence for a post-transcriptional effect. Virology 1992, 188:438-450.
65. Small J.A., Bieberich C., Ghotbi Z., Hess J., Scangos G.A., Clements J.E. The visna virus long terminal repeat directs expression of a reporter gene in activated macrophages, lymphocytes, and the central nervous systems of transgenic mice. J Virol 1989, 63:1891-1896.
66. Clements J.E., Payne S.L. Molecular basis of the pathobiology of lentiviruses. Virus Res 1994, 32:97-109.
67. Clements J.E., Zink M.C. Molecular biology and pathogenesis of animal lentivirus infections. Clin Microbiol Rev 1996, 9:100-117.
68. Blacklaws B., Harkiss G.D. Small ruminant lentiviruses and human immunodeficiency virus: cousins that take a long view. Curr HIV Res 2010, 8:26-52.
69. Lairmore M.D., Akita G.Y., Russell H.I., DeMartini J.C. Replication and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate with in vivo pathogenicity. J Virol 1987, 61:4038-4042.
70. Herrmann-Hoesing L.M., Noh S.M., White S.N., Snekvik K.R., Truscott T., Knowles D.P. Peripheral ovine progressive pneumonia provirus levels correlate with and predict histological tissue lesion severity in naturally infected sheep. Clin Vaccine Immunol 2009, 16:551-557.
71. Agnarsdottir G., Thorsteinsdottir H., Oskarsson T., Matthiasdottir S., Haflidadottir B.S., Andresson O.S., et al. The long terminal repeat is a determinant of cell tropism of maedi-visna virus. J Gen Virol 2000, 81:1901-1905.
72. Andresdottir V., Tang X., Agnarsdottir G., Andresson O.S., Georgsson G., Skraban R., et al. Biological and genetic differences between lung- and brain-derived isolates of maedi-visna virus. Virus Genes 1998, 16:281-293.
73. Oskarsson T., Hreggvidsdottir H.S., Agnarsdottir G., Matthiasdottir S., Ogmundsdottir M.H., Jonsson S.R., et al. Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence. J Virol 2007, 81:4052-4057.
74. Barber S.A., Bruett L., Douglass B.R., Herbst D.S., Zink M.C., Clements J.E. Visna virus-induced activation of MAPK is required for virus replication and correlates with virus-induced neuropathology. J Virol 2002, 76:817-828.
75. Murphy B.G., Hotzel I., Jasmer D.P., Davis W.C., Knowles D. TNFalpha and GM-CSF-induced activation of the CAEV promoter is independent of AP-1. Virology 2006, 352:188-199.
76. Tong-Starksen S.E., Sepp T., Pagtakhan A.S. Activation of caprine arthritis-encephalitis virus long terminal repeat by gamma interferon. J Virol 1996, 70:595-599.
77. Ellis J.A., Russell H.I., Du C.W. Effect of selected cytokines on the replication of Corynebacterium pseudotuberculosis and ovine lentiviruses in pulmonary macrophages. Vet Immunol Immunopathol 1994, 40:31-47.
78. Zhang Z., Harkiss G.D., Hopkins J., Woodall C.J. Granulocyte macrophage colony stimulating factor is elevated in alveolar macrophages from sheep naturally infected with maedi-visna virus and stimulates maedi-visna virus replication in macrophages in vitro. Clin Exp Immunol 2002, 129:240-246.
79. Hoshino Y., Nakata K., Hoshino S., Honda Y., Tse D.B., Shioda T., et al. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002, 195:495-505.
80. Narayan O., Cork L.C. Lentiviral diseases of sheep and goats: chronic pneumonia leukoencephalomyelitis and arthritis. Rev Infect Dis 1985, 7:89-98.
81. Zink M.C., Narayan O. Lentivirus-induced interferon inhibits maturation and proliferation of monocytes and restricts the replication of caprine arthritis-encephalitis virus. J Virol 1989, 63:2578-2584.
82. Juste R.A., Ott T.L., Kwang J., Bazer F.W., de La Concha-Bermejillo A. Effects of recombinant ovine interferon-tau on ovine lentivirus replication and progression of disease. J Gen Virol 2000, 81:525-532.
83. Gudmundsson B., Jonsson S.R., Olafsson O., Agnarsdottir G., Matthiasdottir S., Georgsson G., et al. Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo. J Virol 2005, 79:15038-15042.
84. Neil S., Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J Interferon Cytokine Res 2009, 29:569-580.
85. Leroux C., Issel C.J., Montelaro R.C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J Virol 1997, 71:9627-9639.
86. Craigo J.K., Montelaro R.C. EIAV envelope diversity: shaping viral persistence and encumbering vaccine efficacy. Curr HIV Res 2010, 8:81-86.
87. Hoxie J.A. Toward an antibody-based HIV-1 vaccine. Annu Rev Med 2010, 61:135-152.
88. Kennedy-Stoskopf S., Narayan O. Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol 1986, 59:37-44.
89. Jolly P.E., Huso D.L., Sheffer D., Narayan O. Modulation of lentivirus replication by antibodies: Fc portion of immunoglobulin molecule is essential for enhancement of binding, internalization, and neutralization of visna virus in macrophages. J Virol 1989, 63:1811-1813.
90. Grund C.H., Lechman E.R., Pezzuolo N.A., Issel C.J., Montelaro R.C. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies. J Gen Virol 1996, 77(Pt 3):435-442.
91. Beck Z., Prohaszka Z., Fust G. Traitors of the immune system-enhancing antibodies in HIV infection: their possible implication in HIV vaccine development. Vaccine 2008, 26:3078-3085.
92. Bird P., Reyburn H.T., Blacklaws B.A., Allen D., Nettleton P., Yirrell D.L., et al. The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein. Clin Exp Immunol 1995, 102:274-280.
93. Mehta P.D., Thormar H. Neutralizing activity in isolated serum antibody fractions from visna-infected sheep. Infect Immun 1974, 10:678-680.
94. Trujillo J.D., Hotzel K.J., Snekvik K.R., Cheevers W.P. Antibody response to the surface envelope of caprine arthritis-encephalitis lentivirus: disease status is predicted by SU antibody isotype. Virology 2004, 325:129-136.
95. Estes D.M., Brown W.C. Type 1 and type 2 responses in regulation of Ig isotype expression in cattle. Vet Immunol Immunopathol 2002, 90:1-10.
96. Singh I., McConnell I., Dalziel R., Blacklaws B.A. Serum containing ovine IgG2 antibody specific for maedi visna virus envelope glycoprotein mediates antibody dependent cellular cytotoxicity. Vet Immunol Immunopathol 2006, 113:357-366.
97. Cheevers W.P., Beyer J.C., Knowles D.P. Type 1 and type 2 cytokine gene expression by viral gp135 surface protein-activated T lymphocytes in caprine arthritis-encephalitis lentivirus infection. J Virol 1997, 71:6259-6263.
98. Hessell A.J., Hangartner L., Hunter M., Havenith C.E., Beurskens F.J., Bakker J.M., et al. Fc receptor but not complement binding is important in antibody protection against HIV. Nature 2007, 449:101-104.
99. Holl V., Peressin M., Decoville T., Schmidt S., Zolla-Pazner S., Aubertin A.M., et al. Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells. J Virol 2006, 80:6177-6181.
100. Reina R., Glaria I., Benavides J., de Andres X., Crespo H., Solano C., et al. Association of CD80 and CD86 expression levels with disease status of Visna/Maedi virus infected sheep. Viral Immunol 2007, 20:609-622.
101. Singh I., McConnell I., Blacklaws B. Immune response to individual maedi-visna virus gag antigens. J Virol 2006, 80:912-919.
102. Eriksson K., McInnes E., Ryan S., Tonks P., McConnell I., Blacklaws B. In vivo depletion of CD8+ cells does not affect primary maedi visna virus infection in sheep. Vet Immunol Immunopathol 1999, 70:173-187.
103. Eriksson K., McInnes E., Ryan S., Tonks P., McConnell I., Blacklaws B. CD4(+) T-cells are required for the establishment of maedi-visna virus infection in macrophages but not dendritic cells in vivo. Virology 1999, 258:355-364.
104. Koup R.A., Safrit J.T., Cao Y., Andrews C.A., McLeod G., Borkowsky W., et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol 1994, 68:4650-4655.
105. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110.
106. Goulder P., Price D., Nowak M., Rowland-Jones S., Phillips R., McMichael A. Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses. Immunol Rev 1997, 159:17-29.
107. Jin X., Bauer D.E., Tuttleton S.E., Lewin S., Gettie A., Blanchard J., et al. Dramatic rise in plasma viremia after CD8+ T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 1999, 189:991-998.
108. Schmitz J.E., Kuroda M.J., Santra S., Sasseville V.G., Simon M.A., Lifton M.A., et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 1999, 283:857-860.
109. Gallimore A., Cranage M., Cook N., Almond N., Bootman J., Rud E., et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1995, 1:1167-1173.
110. Yant L.J., Friedrich T.C., Johnson R.C., May G.E., Maness N.J., Enz A.M., et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2006, 80:5074-5077.
111. Pereyra F., Jia X., McLaren P.J., Telenti A., de Bakker P.I., Walker B.D., et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 2010, 330:1551-1557.
112. Freel S.A., Saunders K.O., Tomaras G.D. CD8(+)T-cell-mediated control of HIV-1 and SIV infection. Immunol Res 2011, 49:135-146.
113. Pu R., Omori M., Okada S., Rine S.L., Lewis B.A., Lipton E., et al. MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors. Cell Immunol 1999, 198:30-43.
114. McGuire T.C., Fraser D.G., Mealey R.H. Cytotoxic T lymphocytes in protection against equine infectious anemia virus. Anim Health Res Rev 2004, 5:271-276.
115. Bird P., Blacklaws B., Reyburn H.T., Allen D., Hopkins J., Sargan D., et al. Early events in immune evasion by the lentivirus maedi-visna occurring within infected lymphoid tissue. J Virol 1993, 67:5187-5197.
116. Blacklaws B.A., Bird P., Allen D., Roy D.J., MacLennan I.C., Hopkins J., et al. Initial lentivirus-host interactions within lymph nodes: a study of maedi-visna virus infection in sheep. J Virol 1995, 69:1400-1407.
117. Lairmore M.D., Rosadio R.H., DeMartini J.C. Ovine lentivirus lymphoid interstitial pneumonia. Rapid induction in neonatal lambs. Am J Pathol 1986, 125:173-181.
118. Benavides J., Garcia-Pariente C., Ferreras M.C., Fuertes M., Garcia-Marin J.F., Perez V. Diagnosis of clinical cases of the nervous form of Maedi-Visna in 4- and 6-month-old lambs. Vet J 2007, 174:655-658.
119. Norman S., Smith M.C. Caprine arthritis-encephalitis: review of the neurologic form in 30 cases. J Am Vet Med Assoc 1983, 182:1342-1345.
120. Ruff G., Lazary S. Evidence for linkage between the caprine leucocyte antigen (CLA) system and susceptibility to CAE virus-induced arthritis in goats. Immunogenetics 1988, 28:303-309.
121. Ruff G., Maillard J.C., Camus E., Depres E., Matheron G. Occurrence of caprine leucocyte antigens (CLA) in Creole goats susceptible/resistant to heartwater. Rev Elev Med Vet Pays Trop 1993, 46:205-207.
122. van der Molen E.J., Houwers D.J. Indurative lymphocytic mastitis in sheep after experimental infection with maedivisna virus. Vet Q 1987, 9:193-202.
123. Lechner F., Vogt H.R., Seow H.F., Bertoni G., Cheevers W.P., von Bodungen U., et al. Expression of cytokine mRNA in lentivirus-induced arthritis. Am J Pathol 1997, 151:1053-1065.
124. Nathanson N., Panitch H., Palsson P.A., Petursson G., Georgsson G. Pathogenesis of visna. II. Effect of immunosuppression upon early central nervous system lesions. Lab Invest 1976, 35:444-451.
125. McGuire T.C. The immune response to viral antigens as a determinant of arthritis in caprine arthritis-encephalitis virus infection. Vet Immunol Immunopathol 1987, 17:465-470.
126. Panitch H., Petursson G., Georgsson G., Palsson P.A., Nathanson N. Pathogenesis of visna. III. Immune responses to central nervous system antigens in experimental allergic encephalomyelitis and visna. Lab Invest 1976, 35:452-460.
127. Davies J.M., Watt N.J., Torsteinsdottir S., Carnegie P.R. Mimicry of a 21.5kDa myelin basic protein peptide by a Maedi Visna virus polymerase peptide does not contribute to the pathogenesis of encephalitis in sheep. Vet Immunol Immunopathol 1996, 55:127-139.
128. Harkiss G.D., Veitch D., Dickson L., Watt N.J. Autoimmune reactivity in sheep induced by the visna retrovirus. J Autoimmun 1993, 6:63-75.
129. Brodie S.J., Marcom K.A., Pearson L.D., Anderson B.C., de la Concha-Bermejillo A., Ellis J.A., et al. Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia. J Infect Dis 1992, 166:531-541.
130. Zhang Z., Watt N.J., Hopkins J., Harkiss G., Woodall C.J. Quantitative analysis of maedi-visna virus DNA load in peripheral blood monocytes and alveolar macrophages. J Virol Methods 2000, 86:13-20.
131. Zar H.J. Chronic lung disease in human immunodeficiency virus (HIV) infected children. Pediatr Pulmonol 2008, 43:1-10.
132. Gray F., Scaravilli F., Everall I., Chretien F., An S., Boche D., et al. Neuropathology of early HIV-1 infection. Brain Pathol 1996, 6:1-15.
133. Everall I.P., Hansen L.A., Masliah E. The shifting patterns of HIV encephalitis neuropathology. Neurotox Res 2005, 8:51-61.
134. Yao Q., Frank M., Glynn M., Altman R.D. Rheumatic manifestations in HIV-1 infected in-patients and literature review. Clin Exp Rheumatol 2008, 26:799-806.
135. Cadore J.L., Steiner-Laurent S., Greenland T., Mornex J.F., Loire R. Interstitial lung disease in feline immunodeficiency virus (FIV) infected cats. Res Vet Sci 1997, 62:287-288.
136. Sellon D.C., Fuller F.J., McGuire T.C. The immunopathogenesis of equine infectious anemia virus. Virus Res 1994, 32:111-138.
137. Perryman L.E., O'Rourke K.I., McGuire T.C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J Virol 1988, 62:3073-3076.
138. Desport M., Lewis J. Jembrana disease virus: host responses, viral dynamics and disease control. Curr HIV Res 2010, 8:53-65.
139. Brenchley J.M., Silvestri G., Douek D.C. Nonprogressive and progressive primate immunodeficiency lentivirus infections. Immunity 2010, 32:737-742.
140. Keele B.F., Jones J.H., Terio K.A., Estes J.D., Rudicell R.S., Wilson M.L., et al. Increased mortality and AIDS-like immunopathology in wild chimpanzees infected with SIVcpz. Nature 2009, 460:515-519.
141. Lutley R., Petursson G., Palsson P.A., Georgsson G., Klein J., Nathanson N. Antigenic drift in visna: virus variation during long-term infection of Icelandic sheep. J Gen Virol 1983, 64(Pt 7):1433-1440.
142. McGuire T.C., Norton L.K., O'Rourke K.I., Cheevers W.P. Antigenic variation of neutralization-sensitive epitopes of caprine arthritis-encephalitis lentivirus during persistent arthritis. J Virol 1988, 62:3488-3492.
143. Cheevers W.P., Cordery-Cotter R., McGuire T.C., DeMartini J.C. Neutralizing antibody responses and evolution of antigenic variants in monozygotic twin lambs infected with phenotypically distinct ovine lentiviruses. Virology 1999, 258:382-388.
144. Lichtensteiger C.A., Cheevers W.P., Davis W.C. CD8+ cytotoxic T lymphocytes against antigenic variants of caprine arthritis-encephalitis virus. J Gen Virol 1993, 74(Pt 10):2111-2116.
145. Andresdottir V., Skraban R., Matthiasdottir S., Lutley R., Agnarsdottir G., Thorsteinsdottir H. Selection of antigenic variants in maedi-visna virus infection. J Gen Virol 2002, 83:2543-2551.
146. Cheevers W.P., McGuire T.C. The lentiviruses: maedi/visna, caprine arthritis-encephalitis, and equine infectious anemia. Adv Virus Res 1988, 34:189-215.
147. Klenerman P., Wu Y., Phillips R. HIV: current opinion in escapology. Curr Opin Microbiol 2002, 5:408-413.
148. Crowe S., Zhu T., Muller W.A. The contribution of monocyte infection and trafficking to viral persistence, and maintenance of the viral reservoir in HIV infection. J Leukoc Biol 2003, 74:635-641.
149. Crowe S.M., Sonza S. HIV-1 can be recovered from a variety of cells including peripheral blood monocytes of patients receiving highly active antiretroviral therapy: a further obstacle to eradication. J Leukoc Biol 2000, 68:345-350.
150. Chomont N., El-Far M., Ancuta P., Trautmann L., Procopio F.A., Yassine-Diab B., et al. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat Med 2009, 15:893-900.
151. Leroux C., Cadore J.L., Montelaro R.C. Equine Infectious Anemia Virus (EIAV): what has HIV's country cousin got to tell us?. Vet Res 2004, 35:485-512.
152. Potter S.J., Lemey P., Achaz G., Chew C.B., Vandamme A.M., Dwyer D.E., et al. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J Leukoc Biol 2004, 76:562-570.
153. Harmache A., Vitu C., Guiguen F., Russo P., Bertoni G., Pepin M., et al. Priming with tat-deleted caprine arthritis encephalitis virus (CAEV) proviral DNA or live virus protects goats from challenge with pathogenic CAEV. J Virol 1998, 72:6796-6804.
154. Petursson G., Matthiasdottir S., Svansson V., Andresdottir V., Georgsson G., Martin A.H., et al. Mucosal vaccination with an attenuated maedi-visna virus clone. Vaccine 2005, 23:3223-3228.
155. Cheevers W.P., Knowles D.P., McGuire T.C., Baszler T.V., Hullinger G.A. Caprine arthritis-encephalitis lentivirus (CAEV) challenge of goats immunized with recombinant vaccinia virus expressing CAEV surface and transmembrane envelope glycoproteins. Vet Immunol Immunopathol 1994, 42:237-251.
156. Cheevers W.P., Hotzel I., Beyer J.C., Kumpula-McWhirter N. Immune response to caprine arthritis-encephalitis virus surface protein induced by coimmunization with recombinant vaccinia viruses expressing the caprine arthritis-encephalitis virus envelope gene and caprine interleukin-12. Vaccine 2000, 18:2494-2503.
157. Beyer J.C., Chebloune Y., Mselli-Lakhal L., Hotzel I., Kumpula-McWhirter N., Cheevers W.P. Immunization with plasmid DNA expressing the caprine arthritis-encephalitis virus envelope gene: quantitative and qualitative aspects of antibody response to viral surface glycoprotein. Vaccine 2001, 19:1643-1651.
158. Cheevers W.P., Snekvik K.R., Trujillo J.D., Kumpula-McWhirter N.M., Pretty On Top K.J., Knowles D.P. Prime-boost vaccination with plasmid DNA encoding caprine-arthritis encephalitis lentivirus env and viral SU suppresses challenge virus and development of arthritis. Virology 2003, 306:116-125.
159. de Andres X., Reina R., Ciriza J., Crespo H., Glaria I., Ramirez H., et al. Use of B7 costimulatory molecules as adjuvants in a prime-boost vaccination against Visna/Maedi ovine lentivirus. Vaccine 2009, 27:4591-4600.
160. Niesalla H., de Andres X., Barbezange C., Fraisier C., Reina R., Arnarson H., et al. Systemic DNA immunization against ovine lentivirus using particle-mediated epidermal delivery and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine 2009, 27:260-269.
161. Reina R., Barbezange C., Niesalla H., de Andres X., Arnarson H., Biescas E., et al. Mucosal immunization against ovine lentivirus using PEI-DNA complexes and modified vaccinia Ankara encoding the gag and/or env genes. Vaccine 2008, 26:4494-4505.
162. Gonzalez B., Reina R., Garcia I., Andres S., Glaria I., Alzueta M., et al. Mucosal immunization of sheep with a Maedi-Visna virus (MVV) env DNA vaccine protects against early MVV productive infection. Vaccine 2005, 23:4342-4352.
163. Torsteinsdottir S., Carlsdottir H.M., Svansson V., Matthiasdottir S., Martin A.H., Petursson G. Vaccination of sheep with Maedi-visna virus gag gene and protein, beneficial or harmful?. Vaccine 2007, 25:6713-6720.
164. Lin Y.Z., Shen R.X., Zhu Z.Y., Deng X.L., Cao X.Z., Wang X.F., et al. An attenuated EIAV vaccine strain induces significantly different immune responses from its pathogenic parental strain although with similar in vivo replication pattern. Antiviral Res 2011.
165. Uhl E.W., Heaton-Jones T.G., Pu R., Yamamoto J.K. FIV vaccine development and its importance to veterinary and human medicine: a review FIV vaccine 2002 update and review. Vet Immunol Immunopathol 2002, 90:113-132.
166. Nathanson N., Martin J.R., Georgsson G., Palsson P.A., Lutley R.E., Petursson G. The effect of post-infection immunization on the severity of experimental visna. J Comp Pathol 1981, 91:185-191.
167. McGuire T.C., Adams D.S., Johnson G.C., Klevjer-Anderson P., Barbee D.D., Gorham J.R. Acute arthritis in caprine arthritis-encephalitis virus challenge exposure of vaccinated or persistently infected goats. Am J Vet Res 1986, 47:537-540.
168. Nenci C., Zahno M.L., Vogt H.R., Obexer-Ruff G., Doherr M.G., Zanoni R., et al. Vaccination with a T-cell-priming Gag peptide of caprine arthritis encephalitis virus enhances virus replication transiently in vivo. J Gen Virol 2007, 88:1589-1593.
169. Russo P., Vitu C., Fontaine J.J., Vignoni M. Caprine arthritis-encephalitis: trial of an adjuvant vaccine preparation. I. Clinical and virological study. Comp Immunol Microbiol Infect Dis 1993, 16:131-136.
170. Richardson J., Moraillon A., Baud S., Cuisinier A.M., Sonigo P., Pancino G. Enhancement of feline immunodeficiency virus (FIV) infection after DNA vaccination with the FIV envelope. J Virol 1997, 71:9640-9649.
171. Erhouma E., Guiguen F., Chebloune Y., Gauthier D., Lakhal L.M., Greenland T., et al. Small ruminant lentivirus proviral sequences from wild ibexes in contact with domestic goats. J Gen Virol 2008, 89:1478-1484.
172. Guiguen F., Mselli-Lakhal L., Durand J., Du J., Favier C., Fornazero C., et al. Experimental infection of Mouflon-domestic sheep hybrids with caprine arthritis-encephalitis virus. Am J Vet Res 2000, 61:456-461.
173. Morin T., Guiguen F., Bouzar B.A., Villet S., Greenland T., Grezel D., et al. Clearance of a productive lentivirus infection in calves experimentally inoculated with caprine arthritis-encephalitis virus. J Virol 2003, 77:6430-6437.